CDK9 and malignant colon neoplasm: The role of CDK9 inhibition in modulating the immune system (Figure 2D) has been further elucidated by Zhang et al. In one of their studies, colon cancer cells were treated with the CDK9 inhibitor HH1, and RNA sequencing of the cells identified upregulation of 326 immune-related genes [28].